TEL AVIV, Israel--(BUSINESS WIRE)--Vectorious Medical Technologies Ltd., an innovator in implantable hemodynamic monitoring in heart failure (HF), today announced results of VECTOR-HF I, a ...
Lentiviral vectors have emerged as indispensable tools in gene therapy, offering the ability to integrate therapeutic genes into both dividing and non-dividing cells. Their unique capacity to achieve ...
Led by a team of Cornell faculty, the Northeast Regional Center for Excellence in Vector-Borne Diseases received a five-year, $8.7 million grant from the Centers for Disease Control and Prevention in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback